Company Filing History:
Years Active: 2025
Title: Innovations of Shengyang Wang in Antibody Development
Introduction
Shengyang Wang is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of antibody development, particularly in the context of viral detection and treatment. With a total of 3 patents, his work focuses on innovative solutions for combating influenza and SARS-CoV-2.
Latest Patents
Wang's latest patents include a nanobody targeting influenza A virus nucleoprotein and its application. This invention involves the construction of a nanobody phage library and phage screening technology to obtain a nanobody that specifically binds to the influenza A virus nucleoprotein. The nanobody has promising applications in the early warning of influenza outbreaks and environmental detection.
Another notable patent is the preparation method and application of a single-chain antibody fragment targeting the SARS-CoV-2 nucleocapsid protein. This invention aims to provide a single-chain antibody fragment with high affinity and specificity. The fragment is designed to be used in various immunoassay platforms for SARS-CoV-2 detection, showcasing its potential in addressing the ongoing pandemic.
Career Highlights
Shengyang Wang is affiliated with Nanjing University, where he conducts his research and development activities. His work has garnered attention for its innovative approach to addressing critical health challenges posed by viral infections.
Collaborations
Wang collaborates with notable colleagues such as Yi Luo and Shixiang Yang, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Shengyang Wang's contributions to antibody development represent a significant advancement in the fight against viral infections. His innovative patents and collaborative efforts position him as a key figure in the field of biomedical research.